Enlivex Ltd. (ENLV) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Enlivex Ltd., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$2.61
−3.33% today
Market cap
$4M
Overall quality
52/100
Kronos AI 30-day
—
Enlivex Ltd. (ENLV) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $4M. It trades at $2.61, down 3.33% today. Its overall quality score is 52 out of 100, ranked against the whole US market. 1 analysts' average target of $80.00 implies +2965.1% from today's price.
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $80.00 |
| Low – high | $80.00 – $80.00 |
| Analysts | 1 |
| Upside to average | +2965.1% |
Kronos AI 30-day forecast
No forecast for this listing.
Quality scores
| Profitability | 66 |
| Solvency | 31 |
| Growth | 59 |
| Overall | 52 |
| P/E | 0 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.